Rare disease drug development operates under a unique set of structural constraints. Patient populations are small and dispersed, diagnostic timelines are long,...
Continue reading
There are a number of innovative tools and technologies which are enabling precision patient finding. From AI to e-consent, here we explore how they are changin...
Continue reading
Precision patient finding has the potential to radically reduce the cost of trials and create a more centralized approach which serves to benefit a multitude of...
Continue reading
Clinical trials are essential for bringing new treatments to patients, but they’re not without challenges. Recruiting the right participants, staying on budget,...
Continue reading
Precision patient finding is an evolving field that is growing in line with the demands of precision medicine and rare disease research. Unlike traditional pati...
Continue reading
Sano is proud to support Neuron23 in the NEULARK Phase 2 clinical trial, a groundbreaking study exploring NEU-411, a brain-penetrant LRRK2 inhibitor with the po...
Continue reading
A new partnership will bring together specialist eye care, genetic testing, and patient recruitment to advance both clinical research and care for people affect...
Continue reading
Clinical development is accelerating, yet enrollment continues to be one of the most consistent points of failure. Recruitment delays account for a third of all...
Continue reading
At Sano, we are constantly exploring new ways to use our technology expertise to make a meaningful impact on healthcare. That’s why we’re excited about our part...
Continue reading
In a recent webinar, Hayley Holt, Senior Programme Manager at Sano Genetics, provided an insightful discussion on Sano's innovative approach to patient finding,...
Continue reading